ArticleBrain sciences2021

Near-Infrared MAO A Inhibitor (NMI) Outperformed FDA-Approved Chemotherapeutic Agents in Brain and Other Cancers: A Bioinformatic Analysis of NCI60 Screening Data.

Qianhua Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.